CIK 0001422142
- Non-accelerated filer
- Smaller reporting company
Whitehawk Therapeutics, Inc.
Sign in to watch- Ticker
- WHWK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 611547850
- Phone
- +1 551-321-2234
- Business address
- 2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
- Former names
- Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-14 | ROGERS MICHAEL W | Grant or award · Stock Option (Right to Buy) | +169,500 | 169,500 | ||
| 2019-05-14 | ROGERS MICHAEL W | Grant or award · Stock Option (Right to Buy) | +430,500 | 430,500 | ||
| 2019-02-15 | ROGERS MICHAEL W Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +215,328 | 215,328 | ||
| 2018-04-23 | ROGERS MICHAEL W Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +144,000 | 144,000 | ||
| 2017-12-14 | ROGERS MICHAEL W Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +293,006 | $5.50 | $1.6M | 0 |
Page 1 of 1 · 5 trades